<DOC>
	<DOCNO>NCT01459562</DOCNO>
	<brief_summary>The purpose study determine safety , pharmacodynamic pharmacokinetic profile novel therapeutic drug administer healthy volunteer .</brief_summary>
	<brief_title>First Human Study Anti-IFN Gamma Monoclonal Antibody Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>healthy adult 18 50 year old non smoker able adhere study protocol requirement abnormal clinical safety laboratory parameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>